Walgreens to pay up to $350 million in U.S. opioid settlement
By JAIMIE DING, Associated Press
Walgreens has agreed to pay up to $350 million in a settlement with the U.S. Department of Justice, which said that it illegally filling millions of prescriptions in the last decade for opioids and other controlled substances.
The nationwide drugstore chain must pay the government at least $300 million and will owe another $50 million if the company is sold, merged, or transferred before 2032, according to the settlement reached last Friday.
That would include a potential buyout worth nearly $10 billion by the private equity firm Sycamore Partners that Walgreens announced in early March.
Related Articles
Tackling tariffs: What some companies are saying, and doing, about tariffs
Is your marijuana safe? Lack of data makes it hard to know in the long term
Harvey Weinstein’s rape retrial to open Wednesday with majority-female jury
Colorado’s first-in-the-nation sperm donor rules just took effect. Now lawmakers may roll some back